This inventor holds 3 USPTO granted patents and 8 published patent applications. Top assignee: Prelude Therapeutics Incorporated. Active years: 2023-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2024
Title: Innovations of Xiaowei Wu
Introduction
Xiaowei Wu is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of CDK inhibitors. With a total of three patents to his name, his work has the potential to impact medical treatments significantly.
Latest Patents
Xiaowei Wu's latest patents focus on CDK inhibitors and their use as pharmaceuticals. The disclosures are directed to compounds of Formula I, which include pharmaceutical compositions comprising these compounds. Additionally, methods of their use and preparation are also described in his patents.
Career Highlights
Xiaowei Wu is currently associated with Prelude Therapeutics Incorporated, where he continues to innovate in the pharmaceutical sector. His work is crucial in advancing therapeutic options for various diseases.
Collaborations
Some of his notable coworkers include Andrew Paul Combs and Jincong Zhuo, who collaborate with him on various projects within the company.
Conclusion
Xiaowei Wu's contributions to the field of pharmaceuticals through his patents on CDK inhibitors highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile